Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications.
about
Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levelsIrritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional SyndromesCentral sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disordersMigraine, fibromyalgia, and depression among people with IBS: a prevalence studyThe Quality of Life Scale (QOLS): reliability, validity, and utilizationPsychological illness is commonly associated with functional gastrointestinal disorders and is important to consider during patient consultation: a population-based studyPsychosocial impact of irritable bowel syndrome: A brief reviewIrritable bowel syndrome: relations with functional, mental, and somatoform disordersReview of overlap between thermoregulation and pain modulation in fibromyalgia.Further validation of a model of fibromyalgia syndrome in the rat.Risk for Irritable Bowel Syndrome in Fibromyalgia Patients: A National Database StudyDepression in patients with irritable bowel syndrome in Jos, NigeriaHigh frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome.Irritable bowel syndrome and chronic pelvic pain: a singular or two different clinical syndrome?Costs of care for irritable bowel syndrome patients in a health maintenance organization.Irritable bowel syndrome: a clinical reviewPredictors of patient-assessed illness severity in irritable bowel syndrome.Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study.Duloxetine for the management of fibromyalgia syndrome.Validation of New Symptom-Based Fibromyalgia Criteria for Irritable Bowel Syndrome Co-morbidity Studies.Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuliPatients with irritable bowel syndrome are more burdened by co-morbidity and worry about serious diseases than healthy controls--eight years follow-up of IBS patients in primary careClinical impact of a gluten-free diet on health-related quality of life in seven fibromyalgia syndrome patients with associated celiac diseaseNew insights into the understanding of gastrointestinal dysmotilityVisceral pain: the neurophysiological mechanismPrevalence of restless legs syndrome in patients with irritable bowel syndrome.Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.The prevalence of fibromyalgia in other chronic pain conditions.Association between irritable bowel syndrome and restless legs syndrome: a comparative study with control group.Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspectiveIntrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.Self-reported physical health, mental health, and comorbid diseases among women with irritable bowel syndrome, fibromyalgia, or both compared with healthy control respondents.Movement-evoked hyperalgesia induced by lipopolysaccharides is not suppressed by glucocorticoids.Chronic fatigue in patients with unexplained self-reported food hypersensitivity and irritable bowel syndrome: validation of a Norwegian translation of the Fatigue Impact ScaleFunctional bowel symptoms, fibromyalgia and fatigue: a food-induced triad?Validation of the International Classification of Functioning, Disability and Health Core Set for chronic widespread pain from the perspective of fibromyalgia patientsDysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.Development and validation of new disease-specific measures of somatization and comorbidity in IBS.The epidemiology of irritable bowel syndrome
P2860
Q24293495-8203229E-8502-478B-BB3A-E07722919504Q24601623-52C84882-4444-440E-97D6-B81CEBE8E057Q24604236-257AB0AF-FEF4-47ED-B219-2E9AA17492A2Q24672013-FBE85D84-5524-4FC4-9AA0-B436A4950CC6Q24791280-0B8FE52F-DD0A-4FA7-BD3E-95913355DE61Q24811008-8B260367-D850-4338-87C8-777CE38FCF35Q26776175-4F76CC69-03B8-43B9-AB11-7DB79794B4C6Q26995505-6C0FF984-99A2-4DA2-B0A5-283CDEAF90F1Q30410140-6FCD63A8-42DB-4003-8910-F749B491CF56Q30466207-88ADA1FF-A925-4759-A0FD-EA14ADC4EA0EQ33621435-4AC101A0-7C27-4B92-A007-DDC3788812CCQ33866737-523C53F5-344E-4B9F-AD24-5AD687084A5DQ33873584-6C21B1DB-1955-4394-8B04-2D84BE6407B4Q34098643-D8FD8435-1E5B-4424-867E-C8B0A8BCF880Q34103131-F8EE8664-0C27-4711-A017-ED6B5DCC67E9Q34168517-2ABFB317-2297-4EA8-9AF5-802F81D29FB7Q34170665-6849CEA9-95C9-4144-8FD1-BC904A9259CEQ34254580-6604E072-A00D-4C13-8C91-955B531BFCB9Q34418217-E9CA7F43-F698-4B61-A328-EDE7C926A70DQ34588793-1DC2D385-3024-4467-B88D-C709E1FB6BEBQ34786704-CF0A7A83-138E-4D51-AC72-FC10FE55DA97Q34887939-AB75693D-1F1E-409D-908D-971F93CC5E85Q34985068-E196D222-2CFB-49CE-8C9F-8BC93215C32CQ35037572-324651E9-CBDC-4491-96EC-D633C3F3AFB7Q35161786-9AF18B69-8EF6-4FF1-9686-010133502839Q35164413-3F72417C-1D3D-4703-9BD6-3F846B84C183Q35555727-729718AF-FDE8-4199-843E-6C43C6E322E7Q35596886-83F4D755-5FD0-48FD-8CE5-1C6FFECA254FQ35608619-F949AC35-962A-4D53-8901-B752E47933F2Q36341718-F54A77E6-CD3B-4FE7-8622-E03EE3C224F9Q36379093-9778B1E9-C2AA-4FE2-94DC-834D8BAC13D9Q36470570-9970F6DA-C712-46CC-A06E-FCF0E92BD27BQ36526204-71D308A8-0A74-4F08-AA7F-5F33F991BCC5Q36726966-A6E96360-8C85-4531-A645-BFBB2455AE9FQ36996557-3E396083-4AA3-4CB4-B250-695D946E8310Q37221851-249B02A6-FF0F-48B6-9B36-5A3C60E13C5DQ37270755-8D0C63BC-6A78-4238-BF7C-9EB2C9B22553Q37351023-DB938750-4DE4-456F-A3AA-5A2A5A4B1CDFQ37373916-351A7876-5E2A-444F-8963-7FA7E189DC70Q37577760-E5879173-D991-46ED-8A7A-7FEF87F36595
P2860
Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Fibromyalgia in the irritable ...... nce and clinical implications.
@en
Fibromyalgia in the irritable ...... nce and clinical implications.
@nl
type
label
Fibromyalgia in the irritable ...... nce and clinical implications.
@en
Fibromyalgia in the irritable ...... nce and clinical implications.
@nl
prefLabel
Fibromyalgia in the irritable ...... nce and clinical implications.
@en
Fibromyalgia in the irritable ...... nce and clinical implications.
@nl
P2093
P1476
Fibromyalgia in the irritable ...... nce and clinical implications.
@en
P2093
Abu-Shakrah M
Sperber AD
Weisberg I
P304
P356
10.1016/S0002-9270(99)00702-9
P407
P577
1999-12-01T00:00:00Z